Location History:
- Ridgewood, NJ (US) (2014 - 2015)
- Pawcatuck, CT (US) (2024)
Company Filing History:
1 out of 4,455 
2 out of 832,843 Years Active: 2014-2024
Title: Unveiling the Innovator: Eric Christian Hansen
Introduction:
In the realm of Pawcatuck, CT (US) resides a visionary inventor by the name of Eric Christian Hansen. With a crisp focus on groundbreaking pharmaceutical compositions, Eric has made his mark in the field of abnormal cell growth treatment through his patented invention of a crystalline form of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate.
Latest Patents:
Eric boasts a single patent to his name, the crystalline form of the aforementioned innovative pharmaceutical composition. This patent showcases his dedication to improving the treatment methods for abnormal cell growth in mammals, particularly in humans.
Career Highlights:
Eric Christian Hansen's professional journey has led him to Pfizer Corporation, a renowned pharmaceutical company known for its cutting-edge research and development in healthcare. Through his association with Pfizer, Eric has been able to nurture his inventive spirit and contribute significantly to the advancement of pharmaceutical science.
Collaborations:
In his pursuit of innovation, Eric has collaborated with esteemed coworkers such as Christopher Scott Seadeek and Anil Mahadeo Rane. Together, they have synergized their expertise to further enhance the efficacy of their inventions and propel the field of pharmaceuticals towards new horizons.
Conclusion:
Eric Christian Hansen stands as a beacon of innovation in the pharmaceutical landscape, with his patent paving the way for novel treatment modalities in the realm of abnormal cell growth. His collaborations and career milestones exemplify his commitment to pushing the boundaries of science and revolutionizing healthcare as we know it.